NBS NEWBORN.SOLUTIONS
DEAD

Serial Number

88933443

Owner

NEOS NEW BORN SOLUTION, S.L.

Attorney

Kevin S. Costanza

Filing Date

May 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NBS NEWBORN.SOLUTIONS Trademark

Serial Number: 88933443

NBS NEWBORN.SOLUTIONS is a trademark filed by NEOS NEW BORN SOLUTION, S.L. on May 26, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NEOS NEW BORN SOLUTION, S.L. (2 trademarks)

Parc Científic de Barcelona -
Barcelona E-08028 , ES

Entity Type: 99

Trademark Details

Filing Date

May 26, 2020

Registration Date

Not Registered

Published for Opposition

January 10, 2023

Goods & Services

Diagnostic apparatus for the detection of pathogens for laboratory and research use, none of the aforementioned being related to scientific research consulting in the field of science and technology development services or scientific consulting in the fields of nanotechnology, biotechnology, physics, medicine and diagnostics

Wholesale and retail store services and online wholesale and retail store services via global computer networks of diagnostic products and materials, pharmaceuticals for the treatment of infectious diseases, medical diagnostic reagents and tests for analyzing body fluids, reagents for clinical diagnoses, diagnostic preparations, scientific specimens for laboratory use, diagnostic, examination and monitoring equipment, detection apparatus for medical use, medical instruments for analysis of infectious diseases, medical apparatus and instruments, medical imaging apparatus, instruments for extracting human body fluids, measuring devices for medical use, specimen samplers for medical use, testing apparatus for medical purposes, lancing devices, surgical apparatus and instruments, injectors for medical purposes, apparatus for non-invasive surgery, automated analyzers for body fluids for medical use, apparatus for taking body fluid samples, specimen samplers for medical use, medical specimen cups, testing apparatus for medical purposes, computer software for use in medical decision support systems, health monitoring software, data management software, data processing software, data and file management and database software, artificial intelligence software for analysis; Business administration services; Providing business information via internet, cable network or other forms of data transfer; Sales administration, namely, sales management services; Distribution of prospectuses and samples; Arranging of displays for commercial purposes, none of the aforementioned being related to scientific research consulting in the field of science and technology development services or scientific consulting in the fields of nanotechnology, biotechnology, physics, medicine and diagnostics

Medical screening; Medical services; Medical imaging services; Medical diagnostic services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical health assessment services; Medical assistance; Advisory services relating to medical services; Medical advisory services relating to medical instruments; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by medical laboratories; Medical testing services relating to the diagnosis and treatment of disease, none of the aforementioned being related to scientific research consulting in the field of science and technology development services or scientific consulting in the fields of nanotechnology, biotechnology, physics, medicine and diagnostics

Medical equipment for diagnosis, examination, triaging, screening and monitoring, namely, quantitative ultrasound apparatus incorporating artificial intelligence algorithms; Detecting instruments for medical use, namely, ultrasound apparatus incorporating artificial intelligence algorithms for non-invasively triaging, screening, diagnosing and monitoring infectious diseases; Medical instruments for infectious disease testing, non-invasive triaging, screening, diagnosis and monitoring; Medical imaging apparatus; Medical instruments for the non-invasive analysis of human body fluids; Measuring devices for medical use, namely, quantitative ultrasound using artificial intelligence predictive models for non-invasive white blood cell counting and pathogen identification for detecting, triaging, screening, diagnosis, monitoring of infectious diseases in body fluids, none of the aforementioned being related to scientific research consulting in the field of science and technology development services or scientific consulting in the fields of nanotechnology, biotechnology, physics, medicine and diagnostics

Medical research; Scientific research; Scientific analysis in the field of the non-invasive characterization of superficial serous body fluids to detect, triage, screen, diagnose and monitor infectious diseases; Product development; Development of diagnostic apparatus; Scientific research and development; Product research and development; Development of data processing programs for others; Development of testing methods; Design and development of data processing software; Clinical research in the field of the non-invasive characterization of superficial serous body fluids to detect, triage, screen, diagnose and monitor infectious diseases; Conducting clinical trials for others; Testing of machinery; Genetic research; Medical research laboratory services; Preparation of biological samples for research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials, none of the aforementioned being related to scientific research consulting in the field of science and technology development services or scientific consulting in the fields of nanotechnology, biotechnology, physics, medicine and diagnostics

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 13, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 13, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 13, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 12, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 12, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 6, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 6, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 6, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 14, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 14, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 1, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 1, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 1, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 11, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 11, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 11, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2022 CRFA
ASSIGNED TO LIE
May 3, 2022 ALIE
ASSIGNED TO LIE
Apr 28, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 25, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 26, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 26, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 26, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 22, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 12, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 12, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 12, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2020 NWOS
NEW APPLICATION ENTERED
May 29, 2020 NWAP